Vivanza Biosciences Share Price

4.23-0.08 (-1.85%)
Volume: 35,725

BSE

Closed
Last Updated On: 29 Aug, 2024, 03:30 PM IST

STOCK SCORE

ETPrime Only

TECHNICALS
COMPARE

Vivanza Biosciences Sha...

4.23-0.08 (-1.85%)
Volume: 35,725

Overview
News
Analysis
Recos
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About
More
- MF
- F&O
- Corp Actions
- About
EnglishEnglishहिन्दी ગુજરાતી मराठी বাংলা ಕನ್ನಡ தமிழ்తెలుగు

Vivanza Biosciences share price insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 52.55% outperformed its 3 year CAGR of 38.5%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 1.48% of its operating revenues towards interest expenses and 1.62% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Vivanza Biosciences Share Price Update
Vivanza Biosciences Ltd. share price moved down by -1.85% from its previous close of Rs 4.31. Vivanza Biosciences Ltd. stock last traded price is 4.23
Share Price Value
Today/Current/Last -4.23
Previous Day -4.31

Share Price	Value
Today/Current/Last	-4.23
Previous Day	-4.31

InsightsVivanza Biosciences

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

53.01

EPS - TTM

(₹)

0.08

MCap

(₹ Cr.)

16.92

Sectoral MCap Rank

157

PB Ratio

(x)

3.72

Div Yield

(%)

0.00

Face Value

(₹)

1.00

Beta

VWAP

(₹)

4.23

52W H/L

(₹)

14.60 / 3.70

Vivanza Biosciences Share Price Returns

1 Day	-1.85%
1 Week	-7.44%
1 Month	-11.51%
3 Months	-36.39%
1 Year	-65.04%
3 Years	N.A.
5 Years	N.A.

ET Stock ScreenersTop Score Companies

Check whether Vivanza Biosciences belongs to analysts' top-rated companies list?

View Stock Screeners

Vivanza Biosciences News & Analysis

View all Vivanza Biosciences Share News & Announcements

Vivanza Biosciences Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

View Stock Score on a 10-point scale
See ratings on Earning, Fundamentals, Valuation, Risk & Price
Check stock performance

JOIN ET PRIME

Vivanza Biosciences Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Vivanza Biosciences Financials

Income (P&L)
Balance Sheet
Cash Flow
Ratios

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 52.55% outperformed its 3 year CAGR of 38.5%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 1.48% of its operating revenues towards interest expenses and 1.62% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

Quarterly \| Annual	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total Income	2.44	4.39	6.58	7.67	9.24
Total Income Growth (%)	-44.41	-33.23	-14.26	-16.97	10.52
Total Expenses	2.08	4.57	6.27	7.30	8.64
Total Expenses Growth (%)	-54.38	-27.17	-14.14	-15.44	4.79
EBIT	0.36	-0.17	0.31	0.37	0.60
EBIT Growth (%)	-	-156.53	-16.69	-38.86	405.18
Profit after Tax (PAT)	0.27	-0.41	0.21	0.26	0.49
PAT Growth (%)	-	-300.82	-21.09	-47.14	-
EBIT Margin (%)	14.69	-3.96	4.68	4.82	6.54
Net Profit Margin (%)	10.88	-9.42	3.13	3.40	5.35
Basic EPS (₹)	0.07	-0.10	0.01	0.07	0.12

Quarterly \| Annual	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total Income	0.43	2.27	3.38	3.92	4.89
Total Income Growth (%)	-81.01	-32.93	-13.78	-19.76	-20.39
Total Expenses	0.11	2.44	3.10	3.63	4.45
Total Expenses Growth (%)	-95.43	-21.14	-14.60	-18.50	-25.47
EBIT	0.32	-0.17	0.28	0.30	0.44
EBIT Growth (%)	-	-161.41	-3.63	-32.54	160.14
Profit after Tax (PAT)	0.23	-0.38	0.18	0.19	0.33
PAT Growth (%)	-	-307.24	-2.20	-42.91	-
EBIT Margin (%)	74.11	-7.69	8.40	7.52	8.94
Net Profit Margin (%)	52.55	-16.66	5.39	4.75	6.68
Basic EPS (₹)	0.06	-0.09	0.01	0.05	0.01

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	27.89	18.28	11.23	10.39	10.19
Total Revenue Growth (%)	52.55	62.81	8.04	1.99	283.21
Total Expenses	27.19	17.57	10.90	10.27	10.40
Total Expenses Growth (%)	54.81	61.22	6.09	-1.22	235.35
Profit after Tax (PAT)	0.55	0.60	0.33	0.08	-0.21
PAT Growth (%)	-8.52	79.67	342.02	-	-
Operating Profit Margin (%)	3.98	6.37	7.10	5.97	2.38
Net Profit Margin (%)	1.96	3.35	3.20	0.76	-2.13
Basic EPS (₹)	0.14	1.50	0.83	0.19	-0.51

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	14.47	14.59	9.98	9.72	9.96
Total Revenue Growth (%)	-0.87	46.30	2.60	-2.41	348.38
Total Expenses	14.04	13.91	9.51	9.57	10.17
Total Expenses Growth (%)	0.95	46.21	-0.66	-5.82	280.63
Profit after Tax (PAT)	0.32	0.57	0.46	0.10	-0.20
PAT Growth (%)	-44.23	22.74	364.35	-	-
Operating Profit Margin (%)	5.84	7.78	9.50	6.67	2.45
Net Profit Margin (%)	2.20	4.00	5.06	1.08	-2.16
Basic EPS (₹)	0.08	1.42	1.16	0.25	-0.51

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	19.50	22.48	12.83	8.45	12.36
Total Assets Growth (%)	-13.24	75.25	51.83	-31.64	11.29
Total Liabilities	14.86	18.39	9.33	-	9.27
Total Liabilities Growth (%)	-19.16	96.99	-	-100.00	18.67
Total Equity	4.64	4.09	3.49	3.16	3.08
Total Equity Growth (%)	13.38	17.14	10.54	2.44	-6.25
Current Ratio (x)	1.29	1.15	1.44	0.95	1.01
Total Debt to Equity (x)	1.11	1.95	0.79	0.11	0.13
Contingent Liabilities	-	-	-	-	-

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	16.87	20.44	11.47	7.93	12.28
Total Assets Growth (%)	-17.47	78.20	44.64	-35.42	13.39
Total Liabilities	12.16	16.04	7.64	4.57	9.01
Total Liabilities Growth (%)	-24.19	109.95	67.18	-49.28	22.42
Total Equity	4.72	4.40	3.83	3.37	3.27
Total Equity Growth (%)	7.27	14.88	13.65	3.06	-5.76
Current Ratio (x)	1.26	1.12	1.17	1.19	1.08
Total Debt to Equity (x)	0.69	1.49	0.44	0.05	0.05
Contingent Liabilities	-	-	-	-	-

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	2.04	-0.95	-	-2.76	2.98
Net Cash used in Investing Activities	-0.04	-	-	-0.02	-
Net Cash flow from Financing Activities	-1.98	1.03	-	2.47	-2.75
Net Cash Flow	0.03	0.09	-	-0.32	0.22
Closing Cash & Cash Equivalent	0.17	0.14	-	-3.09	-2.78
Closing Cash & Cash Equivalent Growth (%)	18.45	-104.56	0.00	11.37	-7.44
Total Debt/ CFO (x)	2.53	-8.46	-	-0.13	0.13

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	1.78	0.16	-0.68	-3.08	2.80
Net Cash used in Investing Activities	-0.04	-	-	-0.02	-
Net Cash flow from Financing Activities	-1.76	-0.08	1.07	2.80	-2.58
Net Cash Flow	-0.01	0.09	0.40	-0.30	0.22
Closing Cash & Cash Equivalent	0.09	0.10	-2.72	-3.11	-2.81
Closing Cash & Cash Equivalent Growth (%)	-13.31	-103.84	-12.70	10.68	-7.14
Total Debt/ CFO (x)	1.83	40.85	-2.49	-0.06	0.06

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	11.79	14.62	9.53	2.38	-6.67
Return on Capital Employed (%)	15.13	20.54	12.13	18.70	6.95
Return on Assets (%)	2.80	2.66	2.59	0.89	-1.66
Interest Coverage Ratio (x)	2.71	2.72	1.84	1.26	0.53
Asset Turnover Ratio (x)	1.33	0.85	0.92	117.05	77.85
Price to Earnings (x)	49.75	126.58	227.27	714.29	-25.51
Price to Book (x)	5.86	18.38	21.61	16.54	1.70
EV/EBITDA (x)	28.71	73.00	108.40	92.67	36.64
EBITDA Margin (%)	4.02	6.38	7.17	6.07	2.38

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	6.73	12.93	12.11	2.96	-6.23
Return on Capital Employed (%)	15.33	25.13	22.71	18.29	7.08
Return on Assets (%)	1.88	2.78	4.04	1.25	-1.65
Interest Coverage Ratio (x)	2.07	2.65	2.16	1.32	0.53
Asset Turnover Ratio (x)	0.77	0.89	0.94	116.28	76.80
Price to Earnings (x)	86.21	133.33	163.93	526.32	-25.77
Price to Book (x)	5.76	17.10	19.71	15.53	1.60
EV/EBITDA (x)	35.52	73.70	91.05	88.78	35.57
EBITDA Margin (%)	5.92	7.79	9.58	6.78	2.45

Financial InsightsVivanza Biosciences

Income (P&L)

- Beating 3 Yr Revenue CAGR
  Company's annual revenue growth of 52.55% outperformed its 3 year CAGR of 38.5%. (Source: Consolidated Financials)
- Employee & Interest Expense
  Company has spent 1.48% of its operating revenues towards interest expenses and 1.62% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Vivanza Biosciences Peer Comparison

Vivanza Biosciences Stock Performance
Ratio Performance

CHART
TABLE

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Vivanza Biosciences Stock Performance	-1.85	-3.64	-12.78	-37.05	-63.31	0.00	0.00
Ishita Drugs Stock Performance	-3.82	-3.99	4.08	18.18	13.04	88.41	290.00
Ortin Labs Stock Performance	-1.42	8.09	-3.26	25.32	10.15	-24.59	137.56
Beryl Drugs Stock Performance	-1.63	0.44	2.02	-10.90	59.53	175.63	0.00
Norris Medicine Stock Performance	1.35	6.01	17.00	17.74	26.16	0.00	100.80
Add More

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Vivanza Biosciences	53.01	3.65	11.79	15.13	2.80	38.50	3.98	1.96	0.14	1.29	1.11	2.53
Ishita Drugs	30.75	2.35	7.54	10.83	6.92	2.71	7.09	4.92	2.50	11.14	0.00	0.00
Ortin Labs	-2.13	6.16	-284.74	-144.81	-122.01	-34.45	-312.19	-380.81	-9.89	3.11	0.64	-0.49
Beryl Drugs	26.68	1.81	0.00	0.00	0.00	23.58	8.50	6.21	1.96	0.00	0.00	5.03
Norris Medicine	-15.99	-1.10	0.00	-14.67	-8.38	-22.59	-12.91	-21.05	-1.19	0.67	-1.58	63.68
Add More

Annual Ratios (%)

Choose from Peers

Parmax Pharma
Colinz Labs
Unjha Form
Chemo Pharma
Bacil Pharma

Choose from Stocks

See All Parameters

Peers InsightsVivanza Biosciences

Do you find these insights useful?

hate it
meh
love it

Vivanza Biosciences Shareholding Pattern

QOQ Change
Total Shareholdings

Loading...
Showing Vivanza Biosciences Shareholding as on 30 Jun 2024
Category 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Promoters 40.05 43.24 44.90 47.29
Pledge 0.00 0.00 0.00 0.00
FII 0.00 0.00 0.00 0.00
DII 0.00 0.00 0.00 0.00
Mutual Funds 0.00 0.00 0.00 0.00
Others 59.95 56.76 55.10 52.71
Showing Shareholding as on 30 Jun 2024
Category No. of Shares Percentage % Change QoQ
Promoters 1,60,18,274 40.05 % -3.19
Pledge 0 0.00 % 0.00
Others 2,39,81,726 59.95 % 3.19

Category	30 Jun 2024	31 Mar 2024	31 Dec 2023	30 Sep 2023
Promoters	40.05	43.24	44.90	47.29
Pledge	0.00	0.00	0.00	0.00
FII	0.00	0.00	0.00	0.00
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	59.95	56.76	55.10	52.71

Category	No. of Shares	Percentage	% Change QoQ
Promoters	1,60,18,274	40.05 %	-3.19
Pledge	0	0.00 %	0.00
Others	2,39,81,726	59.95 %	3.19

MF Ownership

MF Ownership details are not available.

Corporate Actions

Vivanza Biosciences Board Meeting/AGM
Vivanza Biosciences Dividends
Others

Meeting Date	Announced on	Purpose	Details
Aug 08, 2024	Aug 02, 2024	Board Meeting	Quarterly Results
Jul 05, 2024	Jul 01, 2024	Board Meeting	Others
Apr 30, 2024	Apr 19, 2024	Board Meeting	Audited Results
Feb 06, 2024	Jan 30, 2024	Board Meeting	Quarterly Results
Oct 26, 2023	Oct 11, 2023	Board Meeting	Quarterly Results

Dividend announcements are not available.
All Types Ex-Date Record Date Announced on Details
Splits Mar 24, 2023 Mar 24, 2023 Jan 24, 2023 Split: Old FV10.0| New FV:1.0

All Types	Ex-Date	Record Date	Announced on	Details
Splits	Mar 24, 2023	Mar 24, 2023	Jan 24, 2023	Split: Old FV10.0\| New FV:1.0

About Vivanza Biosciences

Vivanza Biosciences Ltd., incorporated in the year 1982, is a Small Cap company (having a market cap of Rs 16.92 Crore) operating in Pharmaceuticals sector. Vivanza Biosciences Ltd. key Products/Revenue Segments include Pharmaceutical Products for the year ending 31-Mar-2024. Show More

Executives
Auditors

JA
J A Mehta
Managing Director
AP
A P Shah
Director
HA
H A Parikh
Director
RK
Rina Kumari
Director
JR
J R Bhatt
Chief Financial Officer
AG
A G Bhojwani
Co. Secretary & Compl. Officer
Show More
Shivam Soni & Co.
GMCA & Co.

Industry

Pharma - Indian

Key Indices Listed on

Address

403/TF, Sarthik II,Opp. Rajpath Club,S.G Highway,Ahmedabad, Gujarat - 380054

Contact

[email protected]

http://www.vivanzabiosciences.com

More Details

FAQs about Vivanza Biosciences share

1. What's Vivanza Biosciences share price today and what are Vivanza Biosciences share returns ?
Vivanza Biosciences share price was Rs 4.23 as on 29 Aug, 2024, 03:30 PM IST. Vivanza Biosciences share price was down by 1.85% based on previous share price of Rs 4.39. Vivanza Biosciences share price trend:
- Last 3 Months: Vivanza Biosciences share price moved down by 36.39%
- Last 12 Months: Vivanza Biosciences share price moved down 65.04%
- Last 3 Years: Vivanza Biosciences Share price moved remain unchanged by N.A.
2. What is Vivanza Biosciences's 52 week high / low?
52 Week high of Vivanza Biosciences share is Rs 14.60 while 52 week low is Rs 3.70
3. What is the CAGR of Vivanza Biosciences?
The CAGR of Vivanza Biosciences is 29.53.
4. What is the PE & PB ratio of Vivanza Biosciences?
The PE ratio of Vivanza Biosciences stands at 54.01, while the PB ratio is 3.72.
5. What are the returns for Vivanza Biosciences share?
Return Performance of Vivanza Biosciences Shares:
- 1 Week: Vivanza Biosciences share price moved down by 7.44%
- 3 Month: Vivanza Biosciences share price moved down by 36.39%
- 6 Month: Vivanza Biosciences share price moved down by 49.64%
6. What are the Vivanza Biosciences quarterly results?
On Consoldiated basis, Vivanza Biosciences reported a total income and loss of Rs 2.44 Cr and Rs 0.27 respectively for quarter ending 2024-06-30. Total Income and profit for the year ending 2024-03-31 was Rs 27.89 Cr and Rs 0.55 Cr.
7. What are the key metrics to analyse Vivanza Biosciences Share Price?
Key Metrics for Vivanza Biosciences are:
- PE Ratio of Vivanza Biosciences is 53.01
- Price/Sales ratio of Vivanza Biosciences is 0.98
- Price to Book ratio of Vivanza Biosciences is 3.72
8. What's the market capitalization of Vivanza Biosciences?
Within the Pharmaceuticals sector, Vivanza Biosciences stock has a market cap rank of 157. Vivanza Biosciences has a market cap of Rs 16.92 Cr.
9. Who are the key owners of Vivanza Biosciences stock?
10. Which are the key peers to Vivanza Biosciences?
Within Pharmaceuticals sector Vivanza Biosciences, Ortin Laboratories Ltd., Beryl Drugs Ltd., Colinz Laboratories Ltd., Norris Medicines Ltd., Parmax Pharma Ltd., Unjha Formulations Ltd., Bacil Pharma Ltd., Welcure Drugs & Pharmaceuticals Ltd., Ishita Drugs & Industries Ltd. and Chemo Pharma Laboratories Ltd. are usually compared together by investors for analysis.

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

Vivanza Biosciences Share Price

Vivanza Biosciences Sha...

Vivanza Biosciences share price insights

InsightsVivanza Biosciences

Key Metrics

Key Metrics

Vivanza Biosciences Share Price Returns

ET Stock ScreenersTop Score Companies

Vivanza Biosciences News & Analysis

Vivanza Biosciences Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Vivanza Biosciences Share Recommendations

Vivanza Biosciences Financials

Income (P&L)

Balance Sheet

Cash Flow

Ratios

Insights

Financial InsightsVivanza Biosciences

Vivanza Biosciences Peer Comparison

Vivanza Biosciences Stock Performance

Ratio Performance

Ratio Performance

Peers InsightsVivanza Biosciences

Vivanza Biosciences Shareholding Pattern

QOQ Change

Total Shareholdings

MF Ownership

Top Searches:

Corporate Actions

Vivanza Biosciences Board Meeting/AGM

Vivanza Biosciences Dividends

About Vivanza Biosciences

Executives

Auditors

More Details

FAQs about Vivanza Biosciences share

Trending in Markets

Vivanza Biosciences Quick Links

Equity Quick Links

More from Markets